MaxCyte, Inc.MXCTNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank8
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P8
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-6.68%
202322.05%
202226.65%
2021-13.12%
20200.81%
201956.46%
2018-0.36%
2017140.29%
201656.13%
201520.80%